tiprankstipranks
Advertisement
Advertisement
Tempest Therapeutics Overhauls Leadership and Acquires New Assets
PremiumCompany AnnouncementsTempest Therapeutics Overhauls Leadership and Acquires New Assets
2M ago
Tempest Therapeutics Stockholders Extend Rights Plan and Approvals
Premium
Company Announcements
Tempest Therapeutics Stockholders Extend Rights Plan and Approvals
2M ago
Tempest Therapeutics: Strategic Pivot to Dual‑Target CAR‑T Platform Extends Runway and Resets Investment Thesis to Buy
Premium
Ratings
Tempest Therapeutics: Strategic Pivot to Dual‑Target CAR‑T Platform Extends Runway and Resets Investment Thesis to Buy
2M ago
Tempest Therapeutics prices 1.17M shares at $3.63 in registered direct offering
PremiumThe FlyTempest Therapeutics prices 1.17M shares at $3.63 in registered direct offering
4M ago
Tempest Therpeutics trading resumes
Premium
The Fly
Tempest Therpeutics trading resumes
4M ago
Tempest Therapeutics Announces New Leadership and Acquisition
Premium
Company Announcements
Tempest Therapeutics Announces New Leadership and Acquisition
4M ago
TPST Earnings this Week: How Will it Perform?
PremiumPre-EarningsTPST Earnings this Week: How Will it Perform?
5M ago
Tempest Therapeutics and Adagene’s Promising Advances in Liver Cancer Treatment
Premium
Company Announcements
Tempest Therapeutics and Adagene’s Promising Advances in Liver Cancer Treatment
5M ago
Tempest Therapeutics’ Promising Phase 3 Trial for Liver Cancer Treatment
Premium
Company Announcements
Tempest Therapeutics’ Promising Phase 3 Trial for Liver Cancer Treatment
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100